Literature DB >> 3697860

Incidence of active tuberculosis in the native population of Canada.

D A Enarson, S Grzybowski.   

Abstract

We analysed the incidence rates of active tuberculosis reported between 1970 and 1981 in three groups of people born in Canada: Inuit, registered Indians and others (mainly of European origin). While the rates of tuberculosis were quite low in the last group, which constitutes about 82% of the population of Canada, they were 16 times higher among Indians and 24 times higher among Inuit. Some 20 to 30 years ago the Inuit had the highest recorded rate of tuberculosis in the world; with an intensive program the rate decreased sharply. Such a program has not been implemented among the Indian population, and the incidence rate has not decreased as rapidly. A major effort is required to satisfactorily control tuberculosis among Indians. In addition, we must not allow our efforts to slacken in the control of tuberculosis among the Inuit.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3697860      PMCID: PMC1491042     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  5 in total

1.  Tuberculosis. A look at the world situation.

Authors:  S Grzybowski
Journal:  Chest       Date:  1983-12       Impact factor: 9.410

2.  Tuberculosis in Eskimos.

Authors:  S Grzybowski; K Styblo; E Dorken
Journal:  Tubercle       Date:  1976-12

3.  Tuberculosis: the native Indian viewpoint on its prevention, diagnosis, and treatment.

Authors:  D Jenkins
Journal:  Prev Med       Date:  1977-12       Impact factor: 4.018

Review 4.  Transmission of tubercle bacilli: The effects of chemotherapy.

Authors:  A Rouillon; S Perdrizet; R Parrot
Journal:  Tubercle       Date:  1976-12

5.  Tuberculosis in immigrants to Canada. A study of present-day patterns in relation to immigration trends and birthplace.

Authors:  D Enarson; M J Ashley; S Grzybowski
Journal:  Am Rev Respir Dis       Date:  1979-01
  5 in total
  17 in total

1.  Tuberculosis: 2. History of the disease in Canada.

Authors:  S Grzybowski; E A Allen
Journal:  CMAJ       Date:  1999-04-06       Impact factor: 8.262

Review 2.  Tuberculosis: 3. Epidemiology of the disease in Canada.

Authors:  R Long; H Njoo; E Hershfield
Journal:  CMAJ       Date:  1999-04-20       Impact factor: 8.262

3.  Proficiency testing of drug susceptibility results in the Canadian Network of Public Health TB laboratories.

Authors:  A Laszlo
Journal:  Can J Infect Dis       Date:  1996-11

4.  Utility of gastric aspirates in screening for pulmonary tuberculosis in high risk subjects:The Manitoba experience.

Authors:  A Bahammam; S Choudhri; R Long
Journal:  Can J Infect Dis       Date:  1999-01

5.  An epidemic of primary tuberculosis in a Canadian aboriginal community.

Authors:  M W Mah; E A Fanning
Journal:  Can J Infect Dis       Date:  1991

6.  Marked disparity in the epidemiology of tuberculosis among Aboriginal peoples on the Canadian prairies: the challenges and opportunities.

Authors:  Richard Long; Vernon Hoeppner; Pamela Orr; Martha Ainslie; Malcolm King; Sylvia Abonyi; Maria Mayan; Dennis Kunimoto; Deanne Langlois-Klassen; Courtney Heffernan; Angela Lau; Dick Menzies
Journal:  Can Respir J       Date:  2013-05-28       Impact factor: 2.409

7.  Essentials of tuberculosis control for the practising physician. Tuberculosis Committee, Canadian Thoracic Society.

Authors: 
Journal:  CMAJ       Date:  1994-05-15       Impact factor: 8.262

Review 8.  Age-related changes in the manifestations of tuberculosis. Implications for drug therapy.

Authors:  S Umeki
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

9.  Antituberculous drug resistance in Manitoba from 1980 to 1989.

Authors:  R Long; J Manfreda; L Mendella; J Wolfe; S Parker; E Hershfield
Journal:  CMAJ       Date:  1993-05-01       Impact factor: 8.262

10.  Tuberculosis surveillance in immigrants to Manitoba.

Authors:  P H Orr; J Manfreda; E S Hershfield
Journal:  CMAJ       Date:  1990-03-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.